Position in BIIB
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$745,407
+$112,919 QoQ
Shares Held
3,450
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#500
of 1,031 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRAXIS INVESTMENT MANAGEMENT INC holds $75,615,085 across 8 Drug Manufacturers - General names. BIIB ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,410 | $25,679,798 | |
| 2 | JNJ |
Johnson & Johnson
|
59,055 | $14,998,198 | |
| 3 | ABBV |
AbbVie Inc.
|
54,506 | $13,715,889 | |
| 4 | MRK |
Merck & Co., Inc.
|
70,254 | $9,027,639 | |
| 5 | AMGN |
Amgen Inc
|
12,830 | $4,645,999 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
34,790 | $4,395,368 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
41,770 | $2,406,787 | |
| 8 | BIIB |
Biogen Inc.
This page
|
3,450 | $745,407 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $745,407 | 3,450 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $632,488 | 3,450 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $607,165 | 3,450 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $483,276 | 3,450 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $714,607 | 5,690 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $596,622 | 4,360 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $666,731 | 4,360 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $540,813 | 2,790 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,159,100 | 5,000 | Shares | Sole | 2024-07-03 | |
| 2024-03-31 | $1,078,150 | 5,000 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,293,850 | 5,000 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,015,189 | 3,950 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,125,157 | 3,950 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,098,218 | 3,950 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $1,093,834 | 3,950 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,030,620 | 3,860 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $787,208 | 3,860 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,122,498 | 5,330 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $1,715,428 | 7,150 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,013,104 | 3,580 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,239,646 | 3,580 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $1,001,505 | 3,580 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $876,598 | 3,580 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,080,820 | 3,810 | Shares | Sole | 2021-02-01 | |
| 2020-06-30 | $1,019,365 | 3,810 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $1,205,407 | 3,810 | Shares | Sole | 2020-07-09 | |
| No filing history on record for this holder in this stock. | ||||||